[Gadolinium-containing contrast agents: Gadoterat-meglumine is safe in patients with chronic renal failure]
- PMID: 24432402
- DOI: 10.1055/s-0033-1346806
[Gadolinium-containing contrast agents: Gadoterat-meglumine is safe in patients with chronic renal failure]
Comment on
-
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study).Eur Radiol. 2013 May;23(5):1250-9. doi: 10.1007/s00330-012-2705-x. Epub 2012 Dec 5. Eur Radiol. 2013. PMID: 23212275 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
